What Makes Mesa Laboratories (MLAB) a Valuable Stock?
Diamond Hill Capital, an investment management company, released its “Small Cap Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Posts Tagged ‘NASDAQ:MLAB’
Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance
Conestoga Capital Advisors, an asset management company, released its “Micro-Cap Strategy” second-quarter 2024 investor letter.
Andvari Sold One of its Longest Holdings Mesa Laboratories (MLAB) in Q2
Andvari Associates, an investment management firm, released its second quarter 2024 investor letter, a copy of which can be downloaded here.
Mesa Laboratories (MLAB) Impacted by Slowdown in Pharmaceutical And Biotech Spending
Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
15 Worst Performing Growth Stocks in 2023
In this piece, we will take a look at the fifteen worst performing growth stocks in 2023.
Here’s Why Mesa Laboratories (MLAB) Declined in Q2
Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2023 investor letter.
Is Mesa Laboratories (MLAB) a Growing Stock?
Andvari Associates, an investment management company, released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here.
Here’s Why Mesa Laboratories (MLAB) Declined in Q3
Conestoga Capital Advisors, an asset management company, released its “Small Cap Growth Fund” third-quarter investor letter. A copy of the same can be downloaded here.
Is MLAB A Good Stock To Buy Now?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Hedge Funds Aren’t Crazy About Mesa Laboratories, Inc. (MLAB) Anymore
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Was The Smart Money Right About Mesa Laboratories, Inc. (MLAB)?
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds.
Is Mesa Laboratories, Inc. (MLAB) A Good Stock To Buy ?
The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with China.
Hedge Funds Are Dumping Mesa Laboratories, Inc. (MLAB)
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Have Never Been More Bullish On Mesa Laboratories, Inc. (MLAB)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Is Mesa Laboratories, Inc. (MLAB) A Good Stock To Buy?
"Value has performed relatively poorly since the 2017 shift, but we believe challenges to the S&P 500’s dominance are mounting and resulting active opportunities away from the...
Hedge Fund and Insider Trading News: Carl Icahn, Eddie Lampert, John D. Arnold, Tiger Global Management, Intrepid Potash, Inc. (IPI), Cytocore (MDIT), and More
Activist investor Carl Icahn scored a big payday on Monday after shares of tanker car maker American Railcar Industries surged on news that the company will merge with a subsidiary...
13G Filing: Nine Ten Partners and Mesa Laboratories Inc (MLAB)
You can access the original SEC filing by clicking here.
Insider Buying at 3 Companies Amid Historically Low Insider Buying, Plus Insider Selling at 2 Companies
According to research firm TrimTabs, the dollar volume of insider buying from early-October through the end of last week stood at about $110 million, representing the lowest monthly...
Hedge Funds Are Buying Harvard Bioscience, Inc. (HBIO)
Harvard Bioscience, Inc. (NASDAQ:HBIO) was in 8 hedge funds' portfolio at the end of March.
This Metric Says You Are Smart to Sell STAAR Surgical Company (STAA)
STAAR Surgical Company (NASDAQ:STAA) was in 7 hedge funds' portfolio at the end of March.
This Metric Says You Are Smart to Sell Derma Sciences Inc (DSCI)
Derma Sciences Inc (NASDAQ:DSCI) was in 7 hedge funds' portfolio at the end of the first quarter of 2013. DSCI has seen a decrease in enthusiasm from smart money lately.
Alphatec Holdings Inc (ATEC): Insiders Are Buying, Should You?
Alphatec Holdings Inc (NASDAQ:ATEC) was in 7 hedge funds' portfolio at the end of the first quarter of 2013.
AtriCure Inc. (ATRC): Are Hedge Funds Right About This Stock?
In today’s marketplace, there are tons of indicators market participants can use to monitor the equity markets.
Should You Avoid Alphatec Holdings Inc (ATEC)?
Is Alphatec Holdings Inc (NASDAQ:ATEC) a superb stock to buy now? The best stock pickers are taking a pessimistic view.
